A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms. [electronic resource]
Producer: 20170413Description: 963-8 p. digitalISSN:- 1433-8726
- Adrenergic alpha-Antagonists -- therapeutic use
- Adult
- Cholinergic Antagonists -- therapeutic use
- Female
- Humans
- Male
- Middle Aged
- Postoperative Complications -- drug therapy
- Solifenacin Succinate -- therapeutic use
- Stents -- adverse effects
- Sulfonamides -- therapeutic use
- Tamsulosin
- Ureteral Diseases -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.